CTC Pancreatic Adenocarcinoma

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

October 31, 2019

Conditions
AdenocarcinomaCirculating Tumor CellsPancreatic Neoplasms
Interventions
DRUG

Desflurane

Apply desflurane as anesthetic

Trial Locations (4)

8063

Stadtspital Triemli, Zurich

8091

University Hospital Zurich, Zurich

8401

Kantonsspital Winterthur, Winterthur

9007

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
collaborator

Kantonsspital Winterthur KSW

OTHER

collaborator

Triemli Hospital

OTHER

collaborator

Cantonal Hospital of St. Gallen

OTHER

lead

University of Zurich

OTHER

NCT02335151 - CTC Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter